{ "resourceType" : "CodeSystem", "id" : "mn-cvx", "text" : { "status" : "generated", "div" : "

Generated Narrative: CodeSystem mn-cvx

Properties

This code system defines the following properties for its concepts

NameCodeURIType
statusstatushttp://hl7.org/fhir/concept-properties#statuscode

Concepts

This case-sensitive code system http://hl7.org/fhir/sid/cvx defines the following codes:

CodeDisplayDefinitionstatus
54 adenovirus, type 4adenovirus vaccine, type 4, live, oralretired
55 adenovirus, type 7adenovirus vaccine, type 7, live, oralretired
82 adenovirus, unspecified formulationadenovirus vaccine, unspecified formulationretired
24 Anthrax, pre-exposure prophylaxis, post-exposure prophylaxisAnthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis
19 BCGBacillus Calmette-Guerin vaccine
27 botulinum antitoxin
26 cholera, unspecified formulationcholera vaccine, unspecified formulationretired
29 CMVIGcytomegalovirus immune globulin, intravenous
56 dengue fever tetravalentdengue fever vaccine, tetravalent
12 diphtheria antitoxin
28 DT (pediatric)diphtheria and tetanus toxoids, adsorbed for pediatric useretired
20 DTaPdiphtheria, tetanus toxoids and acellular pertussis vaccine
106 DTaP, 5 pertussis antigensdiphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens
107 DTaP, unspecified formulationdiphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulationretired
110 DTaP-Hep B-IPVDTaP-hepatitis B and poliovirus vaccine
50 DTaP-HibDTaP-Haemophilus influenzae type b conjugate vaccineretired
120 DTaP-Hib-IPVdiphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
130 DTaP-IPVDiphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated
01 DTPdiphtheria, tetanus toxoids and pertussis vaccineretired
22 DTP-HibDTP-Haemophilus influenzae type b conjugate vaccineretired
102 DTP-Hib-Hep BDTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine
57 hantavirushantavirus vaccineretired
52 Hep A, adulthepatitis A vaccine, adult dosage
83 Hep A, ped/adol, 2 dosehepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule
84 Hep A, ped/adol, 3 dosehepatitis A vaccine, pediatric/adolescent dosage, 3 dose scheduleretired
31 Hep A, pediatric, unspecified formulationhepatitis A vaccine, pediatric dosage, unspecified formulationretired
85 Hep A, unspecified formulationhepatitis A vaccine, unspecified formulationretired
104 Hep A-Hep Bhepatitis A and hepatitis B vaccine
30 HBIGhepatitis B immune globulin
08 Hep B, adolescent or pediatrichepatitis B vaccine, pediatric or pediatric/adolescent dosage
42 Hep B, adolescent/high risk infanthepatitis B vaccine, adolescent/high risk infant dosageretired
43 Hep B, adulthepatitis B vaccine, adult dosage
44 Hep B, high-dosage, dialysis or ICHepatitis B vaccine (Hep B), high-dosage, dialysis or immunocompromised patient
45 Hep B, unspecified formulationhepatitis B vaccine, unspecified formulationretired
58 Hep Chepatitis C vaccineretired
59 Hep Ehepatitis E vaccineretired
60 herpes simplex 2herpes simplex virus, type 2 vaccineretired
46 Hib (PRP-D)Haemophilus influenzae type b vaccine, PRP-D conjugateretired
47 Hib (HbOC)Haemophilus influenzae type b vaccine, HbOC conjugateretired
48 Hib (PRP-T)Haemophilus influenzae type b vaccine, PRP-T conjugate
49 Hib (PRP-OMP)Haemophilus influenzae type b vaccine, PRP-OMP conjugate
17 Hib, unspecified formulationHaemophilus influenzae type b vaccine, conjugate unspecified formulationretired
51 Hib-Hep BHaemophilus influenzae type b conjugate and Hepatitis B vaccineretired
61 HIVhuman immunodeficiency virus vaccineretired
118 HPV, bivalenthuman papilloma virus vaccine, bivalentretired
62 HPV, quadrivalenthuman papilloma virus vaccine, quadrivalent
86 IGimmune globulin, intramuscular
87 IGIVimmune globulin, intravenous
14 IG, unspecified formulationimmune globulin, unspecified formulationretired
111 Influenza, live, trivalent, intranasal, PFInfluenza, live, trivalent, intranasal, preservative free
15 influenza, split (incl. purified surface antigen)influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODEretired
16 influenza, wholeinfluenza virus vaccine, whole virusretired
88 influenza, unspecified formulationinfluenza virus vaccine, unspecified formulationretired
123 influenza, H5N1-1203influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)retired
10 IPVpoliovirus vaccine, inactivated
02 OPV, trivalenttrivalent poliovirus vaccine, live, oralretired
89 polio, unspecified formulationpoliovirus vaccine, unspecified formulationretired
39 Japanese encephalitis SCJapanese Encephalitis Vaccine SCretired
63 Junin virusJunin virus vaccineretired
64 leishmaniasisleishmaniasis vaccineretired
65 leprosyleprosy vaccineretired
66 Lyme diseaseLyme disease vaccineretired
03 MMRmeasles, mumps and rubella virus vaccine
04 M/Rmeasles and rubella virus vaccineretired
94 MMRVmeasles, mumps, rubella, and varicella virus vaccine
67 malariamalaria vaccineretired
05 measlesmeasles virus vaccineretired
68 melanomamelanoma vaccineretired
32 meningococcal MPSV4meningococcal polysaccharide vaccine (MPSV4)retired
103 meningococcal C conjugatemeningococcal C conjugate vaccineretired
114 meningococcal MCV4Pmeningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)
108 meningococcal ACWY, unspecified formulationmeningococcal ACWY vaccine, unspecified formulationretired
07 mumpsmumps virus vaccineretired
69 parainfluenza-3parainfluenza-3 virus vaccineretired
11 pertussispertussis vaccineretired
23 plagueplague vaccineretired
33 pneumococcal polysaccharide PPV23pneumococcal polysaccharide vaccine, 23 valent
100 pneumococcal conjugate PCV 7pneumococcal conjugate vaccine, 7 valentretired
109 pneumococcal, unspecified formulationpneumococcal vaccine, unspecified formulationretired
70 Q feverQ fever vaccineretired
18 rabies, intramuscular injectionrabies vaccine, for intramuscular injection RETIRED CODEretired
40 rabies, intradermal injectionrabies vaccine, for intradermal injectionretired
90 rabies, unspecified formulationrabies vaccine, unspecified formulationretired
72 rheumatic feverrheumatic fever vaccineretired
73 Rift Valley feverRift Valley fever vaccineretired
34 RIGrabies immune globulin
119 rotavirus, monovalentrotavirus, live, monovalent vaccine
122 rotavirus, unspecified formulationrotavirus vaccine, unspecified formulationretired
116 rotavirus, pentavalentrotavirus, live, pentavalent vaccine
74 rotavirus, tetravalentrotavirus, live, tetravalent vaccineretired
71 RSV-IGIVrespiratory syncytial virus immune globulin, intravenousretired
93 RSV-MAbrespiratory syncytial virus monoclonal antibody (palivizumab), intramuscular
06 rubellarubella virus vaccineretired
38 rubella/mumpsrubella and mumps virus vaccineretired
76 Staphylococcus bacterio lysateStaphylococcus bacteriophage lysateretired
113 Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbedtetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)
09 Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbedtetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)
115 Tdaptetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed
35 tetanus toxoid, adsorbedretired
112 tetanus toxoid, unspecified formulationretired
77 Tick-borne encephalitis vaccine (non-US)
13 TIGtetanus immune globulin
95 TST-OT tine testtuberculin skin test; old tuberculin, multipuncture deviceretired
96 TST-PPD intradermaltuberculin skin test; purified protein derivative solution, intradermalretired
97 TST-PPD tine testtuberculin skin test; purified protein derivative, multipuncture deviceretired
98 TST, unspecified formulationtuberculin skin test; unspecified formulationretired
78 tularemia vaccineretired
91 typhoid, unspecified formulationtyphoid vaccine, unspecified formulationretired
25 typhoid, oraltyphoid vaccine, live, oral
41 typhoid, parenteraltyphoid vaccine, parenteral, other than acetone-killed, driedretired
53 typhoid, parenteral, AKD (U.S. military)typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)retired
101 typhoid, ViCPstyphoid Vi capsular polysaccharide vaccine
75 Vaccinia (smallpox, monkeypox), liveVaccinia (smallpox, monkeypox) vaccine, live
105 vaccinia (smallpox) dilutedvaccinia (smallpox) vaccine, dilutedretired
79 vaccinia immune globulin
21 varicellavaricella virus vaccine
81 VEE, inactivatedVenezuelan equine encephalitis, inactivatedretired
80 VEE, liveVenezuelan equine encephalitis, live, attenuatedretired
92 VEE, unspecified formulationVenezuelan equine encephalitis vaccine, unspecified formulationretired
36 VZIGvaricella zoster immune globulin
117 VZIG (IND)varicella zoster immune globulin (Investigational New Drug)retired
37 yellow fever liveyellow fever vaccine live
121 zoster livezoster vaccine, liveretired
998 no vaccine administeredretired
999 unknownunknown vaccine or immune globulinretired
99 RESERVED - do not useretired
133 Pneumococcal conjugate PCV 13pneumococcal conjugate vaccine, 13 valent
134 Japanese Encephalitis IMJapanese Encephalitis vaccine for intramuscular administration
137 HPV, unspecified formulationretired
136 Meningococcal MCV4Omeningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)
135 Influenza, high-dose, trivalent, PFInfluenza, high-dose, split virus, trivalent, injectable, preservative free
131 typhus, historicalHistorical record of a typhus vaccinationretired
132 DTaP-IPV-HIB-HEP B, historicalHistorical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine.retired
128 Novel Influenza-H1N1-09, all formulationsNovel influenza-H1N1-09, all formulationsretired
125 Novel Influenza-H1N1-09, nasalNovel Influenza-H1N1-09, live virus for nasal administrationretired
126 Novel influenza-H1N1-09, preservative-freeNovel influenza-H1N1-09, preservative-free, injectableretired
127 Novel influenza-H1N1-09Novel influenza-H1N1-09, injectableretired
138 Td (adult)tetanus and diphtheria toxoids, not adsorbed, for adult useretired
139 Td(adult) unspecified formulationretired
140 Influenza, split virus, trivalent, PFInfluenza, split virus, trivalent, injectable, preservative free
129 Japanese Encephalitis, unspecified formulationJapanese Encephalitis vaccine, unspecified formulationretired
141 Influenza, split virus, trivalent, preservativeInfluenza, split virus, trivalent, injectable, contains preservative
142 tetanus toxoid, not adsorbedretired
143 Adenovirus types 4 and 7Adenovirus, type 4 and type 7, live, oral
144 influenza, seasonal, intradermal, preservative freeseasonal influenza, intradermal, preservative freeretired
145 RSV-MAb (new)respiratory syncytial virus monoclonal antibody (motavizumab), intramuscularretired
146 DTaP,IPV,Hib,HepBDiphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine.
147 meningococcal MCV4, unspecified formulationMeningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)retired
148 Meningococcal C/Y-HIB PRPMeningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccineretired
149 Influenza, live, quadrivalent, intranasal
150 Influenza, split virus, quadrivalent, PFInfluenza, split virus, quadrivalent, injectable, preservative free
151 influenza nasal, unspecified formulationretired
152 Pneumococcal Conjugate, unspecified formulationretired
153 Influenza, MDCK, trivalent, PFInfluenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, preservative free
154 Hep A, IGHepatitis A immune globulinretired
155 Influenza, recombinant, trivalent, PFInfluenza, recombinant, trivalent, injectable, preservative free
156 Rho(D)-IGRho(D) Immune globulin- IV or IM
157 Rho(D) -IG IMRho(D) Immune globulin - IM
158 Influenza, split virus, quadrivalent, preservativeInfluenza, split virus, quadrivalent, injectable, contains preservative
159 Rho(D) - Unspecified formulationRho(D) Unspecified formulationretired
160 Influenza A monovalent (H5N1), ADJUVANTED-2013Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013
801 AS03 Adjuvant
161 Influenza, injectable,quadrivalent, preservative free, pediatric
162 meningococcal B, recombinantmeningococcal B vaccine, fully recombinant
163 meningococcal B, OMVmeningococcal B vaccine, recombinant, OMV, adjuvanted
164 meningococcal B, unspecifiedmeningococcal B, unspecified formulationretired
165 HPV9Human Papillomavirus 9-valent vaccine
166 influenza, intradermal, quadrivalent, preservative freeinfluenza, intradermal, quadrivalent, preservative free, injectableretired
167 meningococcal, unknown serogroupsmeningococcal vaccine of unknown formulation and unknown serogroupsretired
168 Influenza, adjuvanted, trivalent, PFInfluenza, adjuvanted, inactivated, trivalent, injectable, preservative free
169 Hep A, live attenuatedHep A, live attenuated-IM
170 DTAP/IPV/HIB - non-USnon-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)
171 Influenza, MDCK, quadrivalent, PFInfluenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, preservative free
172 cholera, WC-rBS
173 cholera, BivWC
174 cholera, live attenuated
175 Rabies - IM Diploid cell cultureHuman Rabies vaccine from human diploid cell culture
176 Rabies - IM fibroblast cultureHuman rabies vaccine from Chicken fibroblast culture
177 PCV10pneumococcal conjugate vaccine, 10 valent
178 OPV bivalentNon-US bivalent oral polio vaccine (types 1 and 3)
179 OPV ,monovalent, unspecifiedNon-US monovalent oral polio vaccine, unspecified formulation
180 tetanus immune globulinretired
181 anthrax immune globulin
182 OPV, UnspecifiedOral Polio Vaccine, Unspecified formulationretired
183 Yellow fever vaccine live - altYellow fever vaccine live - alternative formulation for vaccine shortage
184 Yellow fever, unspecifiedYellow fever vaccine, unspecified formulationretired
185 Influenza, recombinant, quadrivalent, PFInfluenza, recombinant, quadrivalent, injectable, preservative free
186 Influenza, MDCK, quadrivalent, preservativeInfluenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, contains preservative
187 zoster recombinantzoster vaccine recombinant
188 zoster, unspecified formulationzoster vaccine, unspecified formulationretired
189 HepB-CpGHepatitis B vaccine (recombinant), CpG adjuvanted
190 Typhoid conjugate vaccine (TCV)Typhoid conjugate vaccine (non-US)
191 meningococcal A polysaccharide (non-US)meningococcal A polysaccharide vaccine (non-US)
192 meningococcal AC polysaccharide (non-US)meningococcal AC polysaccharide vaccine (non-US)
193 Hep A-Hep B, pediatric/adolescenthepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US)
194 Influenza, Southern Hemisphereinfluenza, Southern Hemisphere, unspecified formulationretired
195 DT, IPV adsorbedDiphtheria, Tetanus, Poliomyelitis adsorbed
196 Td, adsorbed, preservative free, adult use, Lf unspecifiedtetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified
197 Influenza, high-dose, quadrivalent, PFInfluenza, high-dose, split virus, quadrivalent, injectable, preservative free
200 influenza, Southern Hemisphere, pediatric, preservative freeinfluenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free
201 Influenza, Southern Hemisphere, quadrivalent, PFInfluenza, seasonal, Southern Hemisphere, quadrivalent, 0.5 mL dose, preservative free
202 influenza, Southern Hemisphere, quadrivalent, with preservativeinfluenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative
198 DTP-hepB-Hib Pentavalent Non-USDiphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)
203 meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free
205 Influenza, adjuvanted, quadrivalent, PFInfluenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free
206 Vaccinia, smallpox monkeypox vaccine live, PF, SQ or ID injectionVaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection
207 COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL doseretired
208 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL doseretired
213 SARS-COV-2 (COVID-19) vaccine, UNSPECIFIEDretired
210 COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mLSARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL
212 COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mLSARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mLretired
204 Ebola Zaire vaccine, live, recombinant, 1mL dose
214 Ebola, unspecifiedretired
211 COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mLSARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL doseretired
500 COVID-19 Non-US Vaccine, UNSPECIFIEDSARS-COV-2 (COVID-19) Non-US Vaccine, UNSPECIFIED
501 COVID-19 IV Non-US Vaccine (QAZCOVID-IN)SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN)
502 COVID-19 IV Non-US Vaccine (COVAXIN)SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)
503 COVID-19 LAV Non-US Vaccine (COVIVAC)SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC)
504 COVID-19 VVnr Non-US Vaccine (Sputnik Light)SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light)
505 COVID-19 VVnr Non-US Vaccine (Sputnik V)SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V)
506 COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of BiotechnologySARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology
507 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences)
508 COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention)
509 COVID-19 PS Non-US Vaccine (EpiVacCorona)SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona)
510 COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)
511 COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)
215 Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PFPneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free
216 Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PFPneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free
219 COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucroseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulationretired
217 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucroseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulationretired
218 COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucroseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulationretired
220 HepB recombinant, 3-antigen, Al(OH)3Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvantedretired
221 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL doseretired
222 Tick-borne encephalitis, unspecifiedTick-borne encephalitis vaccine, unspecifiedretired
223 Tick-borne encephalitis, inactivated, PF, 0.25mLTick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose
224 Tick-borne encephalitis, inactivated, PF, 0.5mLTick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose
225 COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mLSARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL doseretired
226 COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mLSARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL doseretired
512 SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz)
513 SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax)
514 SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D)
515 SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901)
516 COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)
517 SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax)
227 COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL doseretired
228 COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL doseretired
229 COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL doseretired
301 COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulationretired
300 COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulationretired
230 COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mLSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL doseretired
518 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)
519 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), ModernaSARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna
520 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTechSARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech
521 COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSKSARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK
231 influenza, Southern Hemisphere, high-dose, quadrivalentinfluenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free
303 RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PFRespiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free
304 Respiratory syncytial virus (RSV), unspecifiedretired
305 RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PFRespiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free
306 RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 monthsRespiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 0.5 mL, neonates and children to 24 months
307 RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 monthsRespiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 1 mL, neonates and children to 24 months
313 COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mLSARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose
308 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mLSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL doseretired
309 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mLSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose
310 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mLSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose
312 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mLSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose
311 COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mLSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose
315 Respiratory syncytial virus (RSV) MAB, unspecifiedRespiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecifiedretired
314 Respiratory syncytial virus (RSV) vaccine, unspecifiedretired
316 Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PFMeningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free
317 Chikungunya live attenuated vaccine, 0.5 mL, PFChikungunya, live attenuated vaccine, 0.5 mL, preservative free
318 Anthrax, post-exposure prophylaxisAnthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis
319 Anthrax vaccine, unspecifiedretired
320 Influenza, MDCK, trivalent, preservativeInfluenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, contains preservative
321 Influenza-avian, H5N8, monovalent, PFInfluenza-avian, H5N8, viral-vector, monovalent, injectable, preservative free
322 Influenza-avian, H5N8, monovalent, preservativeInfluenza-avian, H5N8, viral-vector, monovalent, injectable, contains preservative
324 Poliovirus, inactivated, fractional-dose (fIPV)
323 Influenza-avian, H5, unspecified formulationretired
326 RSV, mRNA, injectable, PFRespiratory syncytial virus (RSV), mRNA, injectable, preservative free
327 Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PFPneumococcal conjugate vaccine, 21 valent (PCV21), polysaccharide CRM197 conjugate, preservative free
328 Meningococcal oligosaccharide (MenACWY), (MenB), PFMeningococcal oligosaccharide conjugated (groups A, C, W, Y) and group B, 0.5 mL, preservative free
329 Chikungunya, VLP, recombinant, 0.8 mL, PFChikungunya, virus-like particle (VLP), recombinant vaccine, 0.8 mL, preservative free
330 Dengue fever, unspecifiedDengue fever, unspecified formulationretired
331 Influenza, Southern Hemisphere, trivalent, PFInfluenza, seasonal, Southern Hemisphere, trivalent, 0.5 mL dose, preservative free
325 Vaccinia (smallpox, monkeypox), unspecifiedretired
332 RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PFRespiratory syncytial virus (RSV), monoclonal antibody, IgG1κ, (clesrovimab-cfor), 0.7 mL, neonate and infant, preservative free
333 Influenza, live, trivalent, intranasal, self/caregiver admin, PFInfluenza, live, trivalent, intranasal, self or caregiver administered, preservative free
334 COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mLSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2 mL dose
337 Influenza, Southern Hemisphere, high-dose, trivalent, PFInfluenza, Southern Hemisphere, high-dose, split virus, trivalent, 0.5 mL, injectable, preservative free
302 COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL doseSARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulationretired
" }, "url" : "http://hl7.org/fhir/sid/cvx", "version" : "0.1.0", "name" : "CVXCodeSystem", "title" : "CDC CVX Vaccine Codes", "status" : "active", "experimental" : false, "date" : "2026-09-08T10:09:36+08:00", "publisher" : "Эрүүл мэндийн хөгжлийн төв (Health Development Center, Mongolia)", "contact" : [{ "name" : "Эрүүл мэндийн хөгжлийн төв (Health Development Center, Mongolia)", "telecom" : [{ "system" : "url", "value" : "https://hdc.gov.mn" }] }, { "name" : "Эрүүл мэндийн хөгжлийн төв (Health Development Center)", "telecom" : [{ "system" : "url", "value" : "https://hdc.gov.mn" }] }], "description" : "CDC CVX кодын жагсаалт. Дархлаажуулалтын вакциныг кодлоход ашиглана. Эх сурвалж: CDC (https://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx)", "jurisdiction" : [{ "coding" : [{ "system" : "urn:iso:std:iso:3166", "code" : "MN" }] }], "caseSensitive" : true, "content" : "complete", "count" : 289, "property" : [{ "code" : "status", "uri" : "http://hl7.org/fhir/concept-properties#status", "type" : "code" }], "concept" : [{ "code" : "54", "display" : "adenovirus, type 4", "definition" : "adenovirus vaccine, type 4, live, oral", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "55", "display" : "adenovirus, type 7", "definition" : "adenovirus vaccine, type 7, live, oral", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "82", "display" : "adenovirus, unspecified formulation", "definition" : "adenovirus vaccine, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "24", "display" : "Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis", "definition" : "Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis" }, { "code" : "19", "display" : "BCG", "definition" : "Bacillus Calmette-Guerin vaccine" }, { "code" : "27", "display" : "botulinum antitoxin" }, { "code" : "26", "display" : "cholera, unspecified formulation", "definition" : "cholera vaccine, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "29", "display" : "CMVIG", "definition" : "cytomegalovirus immune globulin, intravenous" }, { "code" : "56", "display" : "dengue fever tetravalent", "definition" : "dengue fever vaccine, tetravalent" }, { "code" : "12", "display" : "diphtheria antitoxin" }, { "code" : "28", "display" : "DT (pediatric)", "definition" : "diphtheria and tetanus toxoids, adsorbed for pediatric use", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "20", "display" : "DTaP", "definition" : "diphtheria, tetanus toxoids and acellular pertussis vaccine" }, { "code" : "106", "display" : "DTaP, 5 pertussis antigens", "definition" : "diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens" }, { "code" : "107", "display" : "DTaP, unspecified formulation", "definition" : "diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "110", "display" : "DTaP-Hep B-IPV", "definition" : "DTaP-hepatitis B and poliovirus vaccine" }, { "code" : "50", "display" : "DTaP-Hib", "definition" : "DTaP-Haemophilus influenzae type b conjugate vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "120", "display" : "DTaP-Hib-IPV", "definition" : "diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)" }, { "code" : "130", "display" : "DTaP-IPV", "definition" : "Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated" }, { "code" : "01", "display" : "DTP", "definition" : "diphtheria, tetanus toxoids and pertussis vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "22", "display" : "DTP-Hib", "definition" : "DTP-Haemophilus influenzae type b conjugate vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "102", "display" : "DTP-Hib-Hep B", "definition" : "DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine" }, { "code" : "57", "display" : "hantavirus", "definition" : "hantavirus vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "52", "display" : "Hep A, adult", "definition" : "hepatitis A vaccine, adult dosage" }, { "code" : "83", "display" : "Hep A, ped/adol, 2 dose", "definition" : "hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule" }, { "code" : "84", "display" : "Hep A, ped/adol, 3 dose", "definition" : "hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "31", "display" : "Hep A, pediatric, unspecified formulation", "definition" : "hepatitis A vaccine, pediatric dosage, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "85", "display" : "Hep A, unspecified formulation", "definition" : "hepatitis A vaccine, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "104", "display" : "Hep A-Hep B", "definition" : "hepatitis A and hepatitis B vaccine" }, { "code" : "30", "display" : "HBIG", "definition" : "hepatitis B immune globulin" }, { "code" : "08", "display" : "Hep B, adolescent or pediatric", "definition" : "hepatitis B vaccine, pediatric or pediatric/adolescent dosage" }, { "code" : "42", "display" : "Hep B, adolescent/high risk infant", "definition" : "hepatitis B vaccine, adolescent/high risk infant dosage", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "43", "display" : "Hep B, adult", "definition" : "hepatitis B vaccine, adult dosage" }, { "code" : "44", "display" : "Hep B, high-dosage, dialysis or IC", "definition" : "Hepatitis B vaccine (Hep B), high-dosage, dialysis or immunocompromised patient" }, { "code" : "45", "display" : "Hep B, unspecified formulation", "definition" : "hepatitis B vaccine, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "58", "display" : "Hep C", "definition" : "hepatitis C vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "59", "display" : "Hep E", "definition" : "hepatitis E vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "60", "display" : "herpes simplex 2", "definition" : "herpes simplex virus, type 2 vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "46", "display" : "Hib (PRP-D)", "definition" : "Haemophilus influenzae type b vaccine, PRP-D conjugate", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "47", "display" : "Hib (HbOC)", "definition" : "Haemophilus influenzae type b vaccine, HbOC conjugate", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "48", "display" : "Hib (PRP-T)", "definition" : "Haemophilus influenzae type b vaccine, PRP-T conjugate" }, { "code" : "49", "display" : "Hib (PRP-OMP)", "definition" : "Haemophilus influenzae type b vaccine, PRP-OMP conjugate" }, { "code" : "17", "display" : "Hib, unspecified formulation", "definition" : "Haemophilus influenzae type b vaccine, conjugate unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "51", "display" : "Hib-Hep B", "definition" : "Haemophilus influenzae type b conjugate and Hepatitis B vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "61", "display" : "HIV", "definition" : "human immunodeficiency virus vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "118", "display" : "HPV, bivalent", "definition" : "human papilloma virus vaccine, bivalent", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "62", "display" : "HPV, quadrivalent", "definition" : "human papilloma virus vaccine, quadrivalent" }, { "code" : "86", "display" : "IG", "definition" : "immune globulin, intramuscular" }, { "code" : "87", "display" : "IGIV", "definition" : "immune globulin, intravenous" }, { "code" : "14", "display" : "IG, unspecified formulation", "definition" : "immune globulin, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "111", "display" : "Influenza, live, trivalent, intranasal, PF", "definition" : "Influenza, live, trivalent, intranasal, preservative free" }, { "code" : "15", "display" : "influenza, split (incl. purified surface antigen)", "definition" : "influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "16", "display" : "influenza, whole", "definition" : "influenza virus vaccine, whole virus", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "88", "display" : "influenza, unspecified formulation", "definition" : "influenza virus vaccine, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "123", "display" : "influenza, H5N1-1203", "definition" : "influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "10", "display" : "IPV", "definition" : "poliovirus vaccine, inactivated" }, { "code" : "02", "display" : "OPV, trivalent", "definition" : "trivalent poliovirus vaccine, live, oral", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "89", "display" : "polio, unspecified formulation", "definition" : "poliovirus vaccine, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "39", "display" : "Japanese encephalitis SC", "definition" : "Japanese Encephalitis Vaccine SC", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "63", "display" : "Junin virus", "definition" : "Junin virus vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "64", "display" : "leishmaniasis", "definition" : "leishmaniasis vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "65", "display" : "leprosy", "definition" : "leprosy vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "66", "display" : "Lyme disease", "definition" : "Lyme disease vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "03", "display" : "MMR", "definition" : "measles, mumps and rubella virus vaccine" }, { "code" : "04", "display" : "M/R", "definition" : "measles and rubella virus vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "94", "display" : "MMRV", "definition" : "measles, mumps, rubella, and varicella virus vaccine" }, { "code" : "67", "display" : "malaria", "definition" : "malaria vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "05", "display" : "measles", "definition" : "measles virus vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "68", "display" : "melanoma", "definition" : "melanoma vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "32", "display" : "meningococcal MPSV4", "definition" : "meningococcal polysaccharide vaccine (MPSV4)", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "103", "display" : "meningococcal C conjugate", "definition" : "meningococcal C conjugate vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "114", "display" : "meningococcal MCV4P", "definition" : "meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)" }, { "code" : "108", "display" : "meningococcal ACWY, unspecified formulation", "definition" : "meningococcal ACWY vaccine, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "07", "display" : "mumps", "definition" : "mumps virus vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "69", "display" : "parainfluenza-3", "definition" : "parainfluenza-3 virus vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "11", "display" : "pertussis", "definition" : "pertussis vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "23", "display" : "plague", "definition" : "plague vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "33", "display" : "pneumococcal polysaccharide PPV23", "definition" : "pneumococcal polysaccharide vaccine, 23 valent" }, { "code" : "100", "display" : "pneumococcal conjugate PCV 7", "definition" : "pneumococcal conjugate vaccine, 7 valent", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "109", "display" : "pneumococcal, unspecified formulation", "definition" : "pneumococcal vaccine, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "70", "display" : "Q fever", "definition" : "Q fever vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "18", "display" : "rabies, intramuscular injection", "definition" : "rabies vaccine, for intramuscular injection RETIRED CODE", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "40", "display" : "rabies, intradermal injection", "definition" : "rabies vaccine, for intradermal injection", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "90", "display" : "rabies, unspecified formulation", "definition" : "rabies vaccine, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "72", "display" : "rheumatic fever", "definition" : "rheumatic fever vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "73", "display" : "Rift Valley fever", "definition" : "Rift Valley fever vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "34", "display" : "RIG", "definition" : "rabies immune globulin" }, { "code" : "119", "display" : "rotavirus, monovalent", "definition" : "rotavirus, live, monovalent vaccine" }, { "code" : "122", "display" : "rotavirus, unspecified formulation", "definition" : "rotavirus vaccine, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "116", "display" : "rotavirus, pentavalent", "definition" : "rotavirus, live, pentavalent vaccine" }, { "code" : "74", "display" : "rotavirus, tetravalent", "definition" : "rotavirus, live, tetravalent vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "71", "display" : "RSV-IGIV", "definition" : "respiratory syncytial virus immune globulin, intravenous", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "93", "display" : "RSV-MAb", "definition" : "respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular" }, { "code" : "06", "display" : "rubella", "definition" : "rubella virus vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "38", "display" : "rubella/mumps", "definition" : "rubella and mumps virus vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "76", "display" : "Staphylococcus bacterio lysate", "definition" : "Staphylococcus bacteriophage lysate", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "113", "display" : "Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed", "definition" : "tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)" }, { "code" : "09", "display" : "Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed", "definition" : "tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)" }, { "code" : "115", "display" : "Tdap", "definition" : "tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed" }, { "code" : "35", "display" : "tetanus toxoid, adsorbed", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "112", "display" : "tetanus toxoid, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "77", "display" : "Tick-borne encephalitis vaccine (non-US)" }, { "code" : "13", "display" : "TIG", "definition" : "tetanus immune globulin" }, { "code" : "95", "display" : "TST-OT tine test", "definition" : "tuberculin skin test; old tuberculin, multipuncture device", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "96", "display" : "TST-PPD intradermal", "definition" : "tuberculin skin test; purified protein derivative solution, intradermal", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "97", "display" : "TST-PPD tine test", "definition" : "tuberculin skin test; purified protein derivative, multipuncture device", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "98", "display" : "TST, unspecified formulation", "definition" : "tuberculin skin test; unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "78", "display" : "tularemia vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "91", "display" : "typhoid, unspecified formulation", "definition" : "typhoid vaccine, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "25", "display" : "typhoid, oral", "definition" : "typhoid vaccine, live, oral" }, { "code" : "41", "display" : "typhoid, parenteral", "definition" : "typhoid vaccine, parenteral, other than acetone-killed, dried", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "53", "display" : "typhoid, parenteral, AKD (U.S. military)", "definition" : "typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "101", "display" : "typhoid, ViCPs", "definition" : "typhoid Vi capsular polysaccharide vaccine" }, { "code" : "75", "display" : "Vaccinia (smallpox, monkeypox), live", "definition" : "Vaccinia (smallpox, monkeypox) vaccine, live" }, { "code" : "105", "display" : "vaccinia (smallpox) diluted", "definition" : "vaccinia (smallpox) vaccine, diluted", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "79", "display" : "vaccinia immune globulin" }, { "code" : "21", "display" : "varicella", "definition" : "varicella virus vaccine" }, { "code" : "81", "display" : "VEE, inactivated", "definition" : "Venezuelan equine encephalitis, inactivated", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "80", "display" : "VEE, live", "definition" : "Venezuelan equine encephalitis, live, attenuated", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "92", "display" : "VEE, unspecified formulation", "definition" : "Venezuelan equine encephalitis vaccine, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "36", "display" : "VZIG", "definition" : "varicella zoster immune globulin" }, { "code" : "117", "display" : "VZIG (IND)", "definition" : "varicella zoster immune globulin (Investigational New Drug)", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "37", "display" : "yellow fever live", "definition" : "yellow fever vaccine live" }, { "code" : "121", "display" : "zoster live", "definition" : "zoster vaccine, live", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "998", "display" : "no vaccine administered", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "999", "display" : "unknown", "definition" : "unknown vaccine or immune globulin", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "99", "display" : "RESERVED - do not use", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "133", "display" : "Pneumococcal conjugate PCV 13", "definition" : "pneumococcal conjugate vaccine, 13 valent" }, { "code" : "134", "display" : "Japanese Encephalitis IM", "definition" : "Japanese Encephalitis vaccine for intramuscular administration" }, { "code" : "137", "display" : "HPV, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "136", "display" : "Meningococcal MCV4O", "definition" : "meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)" }, { "code" : "135", "display" : "Influenza, high-dose, trivalent, PF", "definition" : "Influenza, high-dose, split virus, trivalent, injectable, preservative free" }, { "code" : "131", "display" : "typhus, historical", "definition" : "Historical record of a typhus vaccination", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "132", "display" : "DTaP-IPV-HIB-HEP B, historical", "definition" : "Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine.", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "128", "display" : "Novel Influenza-H1N1-09, all formulations", "definition" : "Novel influenza-H1N1-09, all formulations", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "125", "display" : "Novel Influenza-H1N1-09, nasal", "definition" : "Novel Influenza-H1N1-09, live virus for nasal administration", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "126", "display" : "Novel influenza-H1N1-09, preservative-free", "definition" : "Novel influenza-H1N1-09, preservative-free, injectable", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "127", "display" : "Novel influenza-H1N1-09", "definition" : "Novel influenza-H1N1-09, injectable", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "138", "display" : "Td (adult)", "definition" : "tetanus and diphtheria toxoids, not adsorbed, for adult use", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "139", "display" : "Td(adult) unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "140", "display" : "Influenza, split virus, trivalent, PF", "definition" : "Influenza, split virus, trivalent, injectable, preservative free" }, { "code" : "129", "display" : "Japanese Encephalitis, unspecified formulation", "definition" : "Japanese Encephalitis vaccine, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "141", "display" : "Influenza, split virus, trivalent, preservative", "definition" : "Influenza, split virus, trivalent, injectable, contains preservative" }, { "code" : "142", "display" : "tetanus toxoid, not adsorbed", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "143", "display" : "Adenovirus types 4 and 7", "definition" : "Adenovirus, type 4 and type 7, live, oral" }, { "code" : "144", "display" : "influenza, seasonal, intradermal, preservative free", "definition" : "seasonal influenza, intradermal, preservative free", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "145", "display" : "RSV-MAb (new)", "definition" : "respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "146", "display" : "DTaP,IPV,Hib,HepB", "definition" : "Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine." }, { "code" : "147", "display" : "meningococcal MCV4, unspecified formulation", "definition" : "Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "148", "display" : "Meningococcal C/Y-HIB PRP", "definition" : "Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "149", "display" : "Influenza, live, quadrivalent, intranasal" }, { "code" : "150", "display" : "Influenza, split virus, quadrivalent, PF", "definition" : "Influenza, split virus, quadrivalent, injectable, preservative free" }, { "code" : "151", "display" : "influenza nasal, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "152", "display" : "Pneumococcal Conjugate, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "153", "display" : "Influenza, MDCK, trivalent, PF", "definition" : "Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, preservative free" }, { "code" : "154", "display" : "Hep A, IG", "definition" : "Hepatitis A immune globulin", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "155", "display" : "Influenza, recombinant, trivalent, PF", "definition" : "Influenza, recombinant, trivalent, injectable, preservative free" }, { "code" : "156", "display" : "Rho(D)-IG", "definition" : "Rho(D) Immune globulin- IV or IM" }, { "code" : "157", "display" : "Rho(D) -IG IM", "definition" : "Rho(D) Immune globulin - IM" }, { "code" : "158", "display" : "Influenza, split virus, quadrivalent, preservative", "definition" : "Influenza, split virus, quadrivalent, injectable, contains preservative" }, { "code" : "159", "display" : "Rho(D) - Unspecified formulation", "definition" : "Rho(D) Unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "160", "display" : "Influenza A monovalent (H5N1), ADJUVANTED-2013", "definition" : "Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013" }, { "code" : "801", "display" : "AS03 Adjuvant" }, { "code" : "161", "display" : "Influenza, injectable,quadrivalent, preservative free, pediatric" }, { "code" : "162", "display" : "meningococcal B, recombinant", "definition" : "meningococcal B vaccine, fully recombinant" }, { "code" : "163", "display" : "meningococcal B, OMV", "definition" : "meningococcal B vaccine, recombinant, OMV, adjuvanted" }, { "code" : "164", "display" : "meningococcal B, unspecified", "definition" : "meningococcal B, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "165", "display" : "HPV9", "definition" : "Human Papillomavirus 9-valent vaccine" }, { "code" : "166", "display" : "influenza, intradermal, quadrivalent, preservative free", "definition" : "influenza, intradermal, quadrivalent, preservative free, injectable", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "167", "display" : "meningococcal, unknown serogroups", "definition" : "meningococcal vaccine of unknown formulation and unknown serogroups", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "168", "display" : "Influenza, adjuvanted, trivalent, PF", "definition" : "Influenza, adjuvanted, inactivated, trivalent, injectable, preservative free" }, { "code" : "169", "display" : "Hep A, live attenuated", "definition" : "Hep A, live attenuated-IM" }, { "code" : "170", "display" : "DTAP/IPV/HIB - non-US", "definition" : "non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)" }, { "code" : "171", "display" : "Influenza, MDCK, quadrivalent, PF", "definition" : "Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, preservative free" }, { "code" : "172", "display" : "cholera, WC-rBS" }, { "code" : "173", "display" : "cholera, BivWC" }, { "code" : "174", "display" : "cholera, live attenuated" }, { "code" : "175", "display" : "Rabies - IM Diploid cell culture", "definition" : "Human Rabies vaccine from human diploid cell culture" }, { "code" : "176", "display" : "Rabies - IM fibroblast culture", "definition" : "Human rabies vaccine from Chicken fibroblast culture" }, { "code" : "177", "display" : "PCV10", "definition" : "pneumococcal conjugate vaccine, 10 valent" }, { "code" : "178", "display" : "OPV bivalent", "definition" : "Non-US bivalent oral polio vaccine (types 1 and 3)" }, { "code" : "179", "display" : "OPV ,monovalent, unspecified", "definition" : "Non-US monovalent oral polio vaccine, unspecified formulation" }, { "code" : "180", "display" : "tetanus immune globulin", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "181", "display" : "anthrax immune globulin" }, { "code" : "182", "display" : "OPV, Unspecified", "definition" : "Oral Polio Vaccine, Unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "183", "display" : "Yellow fever vaccine live - alt", "definition" : "Yellow fever vaccine live - alternative formulation for vaccine shortage" }, { "code" : "184", "display" : "Yellow fever, unspecified", "definition" : "Yellow fever vaccine, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "185", "display" : "Influenza, recombinant, quadrivalent, PF", "definition" : "Influenza, recombinant, quadrivalent, injectable, preservative free" }, { "code" : "186", "display" : "Influenza, MDCK, quadrivalent, preservative", "definition" : "Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, contains preservative" }, { "code" : "187", "display" : "zoster recombinant", "definition" : "zoster vaccine recombinant" }, { "code" : "188", "display" : "zoster, unspecified formulation", "definition" : "zoster vaccine, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "189", "display" : "HepB-CpG", "definition" : "Hepatitis B vaccine (recombinant), CpG adjuvanted" }, { "code" : "190", "display" : "Typhoid conjugate vaccine (TCV)", "definition" : "Typhoid conjugate vaccine (non-US)" }, { "code" : "191", "display" : "meningococcal A polysaccharide (non-US)", "definition" : "meningococcal A polysaccharide vaccine (non-US)" }, { "code" : "192", "display" : "meningococcal AC polysaccharide (non-US)", "definition" : "meningococcal AC polysaccharide vaccine (non-US)" }, { "code" : "193", "display" : "Hep A-Hep B, pediatric/adolescent", "definition" : "hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US)" }, { "code" : "194", "display" : "Influenza, Southern Hemisphere", "definition" : "influenza, Southern Hemisphere, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "195", "display" : "DT, IPV adsorbed", "definition" : "Diphtheria, Tetanus, Poliomyelitis adsorbed" }, { "code" : "196", "display" : "Td, adsorbed, preservative free, adult use, Lf unspecified", "definition" : "tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified" }, { "code" : "197", "display" : "Influenza, high-dose, quadrivalent, PF", "definition" : "Influenza, high-dose, split virus, quadrivalent, injectable, preservative free" }, { "code" : "200", "display" : "influenza, Southern Hemisphere, pediatric, preservative free", "definition" : "influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free" }, { "code" : "201", "display" : "Influenza, Southern Hemisphere, quadrivalent, PF", "definition" : "Influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5 mL dose, preservative free" }, { "code" : "202", "display" : "influenza, Southern Hemisphere, quadrivalent, with preservative", "definition" : "influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative" }, { "code" : "198", "display" : "DTP-hepB-Hib Pentavalent Non-US", "definition" : "Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)" }, { "code" : "203", "display" : "meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)", "definition" : "meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free" }, { "code" : "205", "display" : "Influenza, adjuvanted, quadrivalent, PF", "definition" : "Influenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free" }, { "code" : "206", "display" : "Vaccinia, smallpox monkeypox vaccine live, PF, SQ or ID injection", "definition" : "Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection" }, { "code" : "207", "display" : "COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "208", "display" : "COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "213", "display" : "SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "210", "display" : "COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL", "definition" : "SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL" }, { "code" : "212", "display" : "COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL", "definition" : "SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "204", "display" : "Ebola Zaire vaccine, live, recombinant, 1mL dose" }, { "code" : "214", "display" : "Ebola, unspecified", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "211", "display" : "COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL", "definition" : "SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "500", "display" : "COVID-19 Non-US Vaccine, UNSPECIFIED", "definition" : "SARS-COV-2 (COVID-19) Non-US Vaccine, UNSPECIFIED" }, { "code" : "501", "display" : "COVID-19 IV Non-US Vaccine (QAZCOVID-IN)", "definition" : "SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN)" }, { "code" : "502", "display" : "COVID-19 IV Non-US Vaccine (COVAXIN)", "definition" : "SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)" }, { "code" : "503", "display" : "COVID-19 LAV Non-US Vaccine (COVIVAC)", "definition" : "SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC)" }, { "code" : "504", "display" : "COVID-19 VVnr Non-US Vaccine (Sputnik Light)", "definition" : "SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light)" }, { "code" : "505", "display" : "COVID-19 VVnr Non-US Vaccine (Sputnik V)", "definition" : "SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V)" }, { "code" : "506", "display" : "COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology", "definition" : "SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology" }, { "code" : "507", "display" : "COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)", "definition" : "SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences)" }, { "code" : "508", "display" : "COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)", "definition" : "SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention)" }, { "code" : "509", "display" : "COVID-19 PS Non-US Vaccine (EpiVacCorona)", "definition" : "SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona)" }, { "code" : "510", "display" : "COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)", "definition" : "SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)" }, { "code" : "511", "display" : "COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)", "definition" : "SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)" }, { "code" : "215", "display" : "Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF", "definition" : "Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free" }, { "code" : "216", "display" : "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF", "definition" : "Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free" }, { "code" : "219", "display" : "COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "217", "display" : "COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "218", "display" : "COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "220", "display" : "HepB recombinant, 3-antigen, Al(OH)3", "definition" : "Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "221", "display" : "COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "222", "display" : "Tick-borne encephalitis, unspecified", "definition" : "Tick-borne encephalitis vaccine, unspecified", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "223", "display" : "Tick-borne encephalitis, inactivated, PF, 0.25mL", "definition" : "Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose" }, { "code" : "224", "display" : "Tick-borne encephalitis, inactivated, PF, 0.5mL", "definition" : "Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose" }, { "code" : "225", "display" : "COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL", "definition" : "SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "226", "display" : "COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL", "definition" : "SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "512", "display" : "SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)", "definition" : "SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz)" }, { "code" : "513", "display" : "SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)", "definition" : "SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax)" }, { "code" : "514", "display" : "SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)", "definition" : "SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D)" }, { "code" : "515", "display" : "SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)", "definition" : "SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901)" }, { "code" : "516", "display" : "COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)", "definition" : "SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)" }, { "code" : "517", "display" : "SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)", "definition" : "SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax)" }, { "code" : "227", "display" : "COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "228", "display" : "COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "229", "display" : "COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "301", "display" : "COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "300", "display" : "COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "230", "display" : "COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "518", "display" : "COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)", "definition" : "SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)" }, { "code" : "519", "display" : "COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna", "definition" : "SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna" }, { "code" : "520", "display" : "COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech", "definition" : "SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech" }, { "code" : "521", "display" : "COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK", "definition" : "SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK" }, { "code" : "231", "display" : "influenza, Southern Hemisphere, high-dose, quadrivalent", "definition" : "influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free" }, { "code" : "303", "display" : "RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF", "definition" : "Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free" }, { "code" : "304", "display" : "Respiratory syncytial virus (RSV), unspecified", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "305", "display" : "RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF", "definition" : "Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free" }, { "code" : "306", "display" : "RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months", "definition" : "Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 0.5 mL, neonates and children to 24 months" }, { "code" : "307", "display" : "RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months", "definition" : "Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 1 mL, neonates and children to 24 months" }, { "code" : "313", "display" : "COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL", "definition" : "SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose" }, { "code" : "308", "display" : "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "309", "display" : "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose" }, { "code" : "310", "display" : "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose" }, { "code" : "312", "display" : "COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose" }, { "code" : "311", "display" : "COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose" }, { "code" : "315", "display" : "Respiratory syncytial virus (RSV) MAB, unspecified", "definition" : "Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "314", "display" : "Respiratory syncytial virus (RSV) vaccine, unspecified", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "316", "display" : "Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF", "definition" : "Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free" }, { "code" : "317", "display" : "Chikungunya live attenuated vaccine, 0.5 mL, PF", "definition" : "Chikungunya, live attenuated vaccine, 0.5 mL, preservative free" }, { "code" : "318", "display" : "Anthrax, post-exposure prophylaxis", "definition" : "Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis" }, { "code" : "319", "display" : "Anthrax vaccine, unspecified", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "320", "display" : "Influenza, MDCK, trivalent, preservative", "definition" : "Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, contains preservative" }, { "code" : "321", "display" : "Influenza-avian, H5N8, monovalent, PF", "definition" : "Influenza-avian, H5N8, viral-vector, monovalent, injectable, preservative free" }, { "code" : "322", "display" : "Influenza-avian, H5N8, monovalent, preservative", "definition" : "Influenza-avian, H5N8, viral-vector, monovalent, injectable, contains preservative" }, { "code" : "324", "display" : "Poliovirus, inactivated, fractional-dose (fIPV)" }, { "code" : "323", "display" : "Influenza-avian, H5, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "326", "display" : "RSV, mRNA, injectable, PF", "definition" : "Respiratory syncytial virus (RSV), mRNA, injectable, preservative free" }, { "code" : "327", "display" : "Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF", "definition" : "Pneumococcal conjugate vaccine, 21 valent (PCV21), polysaccharide CRM197 conjugate, preservative free" }, { "code" : "328", "display" : "Meningococcal oligosaccharide (MenACWY), (MenB), PF", "definition" : "Meningococcal oligosaccharide conjugated (groups A, C, W, Y) and group B, 0.5 mL, preservative free" }, { "code" : "329", "display" : "Chikungunya, VLP, recombinant, 0.8 mL, PF", "definition" : "Chikungunya, virus-like particle (VLP), recombinant vaccine, 0.8 mL, preservative free" }, { "code" : "330", "display" : "Dengue fever, unspecified", "definition" : "Dengue fever, unspecified formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "331", "display" : "Influenza, Southern Hemisphere, trivalent, PF", "definition" : "Influenza, seasonal, Southern Hemisphere, trivalent, 0.5 mL dose, preservative free" }, { "code" : "325", "display" : "Vaccinia (smallpox, monkeypox), unspecified", "property" : [{ "code" : "status", "valueCode" : "retired" }] }, { "code" : "332", "display" : "RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF", "definition" : "Respiratory syncytial virus (RSV), monoclonal antibody, IgG1κ, (clesrovimab-cfor), 0.7 mL, neonate and infant, preservative free" }, { "code" : "333", "display" : "Influenza, live, trivalent, intranasal, self/caregiver admin, PF", "definition" : "Influenza, live, trivalent, intranasal, self or caregiver administered, preservative free" }, { "code" : "334", "display" : "COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2 mL dose" }, { "code" : "337", "display" : "Influenza, Southern Hemisphere, high-dose, trivalent, PF", "definition" : "Influenza, Southern Hemisphere, high-dose, split virus, trivalent, 0.5 mL, injectable, preservative free" }, { "code" : "302", "display" : "COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose", "definition" : "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation", "property" : [{ "code" : "status", "valueCode" : "retired" }] }] }